IV nitroglycerine alternatives: Difference between revisions

 
(One intermediate revision by one other user not shown)
Line 25: Line 25:
<references>
<references>


[[Category:Drugs]]
[[Category:Pharmacology]]
[[Category:Cardiology]]

Latest revision as of 20:51, 22 September 2019

Background

  • Suggestions for substitution during the IV shortage

Nitroglycerine Bioavailability

  • Oral [1]: <1%
  • Sublingual [1]: 38% (15-40%)
  • Topical [1]: 72%

Half-life[2]: 0.05 h

Suggested Substitutions[3]

See Also

References

<references>